Cargando…

COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies

Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronaviru...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauf, Abdur, Abu-Izneid, Tareq, Olatunde, Ahmed, Ahmed Khalil, Anees, Alhumaydhi, Fahad A., Tufail, Tabussam, Shariati, Mohammad Ali, Rebezov, Maksim, Almarhoon, Zainab M., Mabkhot, Yahia N., Alsayari, Abdulrhman, Rengasamy, Kannan R. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662254/
https://www.ncbi.nlm.nih.gov/pubmed/33158234
http://dx.doi.org/10.3390/ijerph17218155
_version_ 1783609357184794624
author Rauf, Abdur
Abu-Izneid, Tareq
Olatunde, Ahmed
Ahmed Khalil, Anees
Alhumaydhi, Fahad A.
Tufail, Tabussam
Shariati, Mohammad Ali
Rebezov, Maksim
Almarhoon, Zainab M.
Mabkhot, Yahia N.
Alsayari, Abdulrhman
Rengasamy, Kannan R. R.
author_facet Rauf, Abdur
Abu-Izneid, Tareq
Olatunde, Ahmed
Ahmed Khalil, Anees
Alhumaydhi, Fahad A.
Tufail, Tabussam
Shariati, Mohammad Ali
Rebezov, Maksim
Almarhoon, Zainab M.
Mabkhot, Yahia N.
Alsayari, Abdulrhman
Rengasamy, Kannan R. R.
author_sort Rauf, Abdur
collection PubMed
description Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronavirus. Interestingly, the virus binds with angiotensin-converting enzyme-2 found in host cells, through the spike (S) protein that exists on its surface. This binding causes the entry of the virus into cells of the host organism. The actual mechanism used by the COVID-19 virus to induce disease is still speculative. A total of 44,322,504 cases, a 1,173,189 death toll and 32,486,703 recovery cases have been reported in 217 countries globally as of 28 October 2020. Symptoms from the infection of the virus include chest pain, fever, fatigue, nausea, and others. Acute respiratory stress syndrome, arrhythmia, and shock are some of the chronic manifestations recorded in severe COVID-19. Transmission is majorly by individual-to-individual through coughing, sneezing, etc. The lack of knowledge regarding the mechanism of and immune response to the virus has posed a challenge in the development of a novel drug and vaccine. Currently, treatment of the disease involves the use of anti-viral medications such as lopinavir, remdesivir, and other drugs. These drugs show some efficacy in the management of COVID-19. Studies are still on-going for the development of an ideal and novel drug for treatment. In terms of natural product intervention, Traditional Chinese Medicines (TCM) have been employed to alleviate the clinical manifestation and severity of the disease and have shown some efficacy. This review presents an updated detailed overview of COVID-19 and the virus, concerning its structure, epidemiology, symptoms and transmission, immune responses, and current interventions, and highlights the potential of TCM. It is anticipated that this review will further add to the understanding of COVID-19 and the virus, hence opening new research perspectives.
format Online
Article
Text
id pubmed-7662254
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76622542020-11-14 COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies Rauf, Abdur Abu-Izneid, Tareq Olatunde, Ahmed Ahmed Khalil, Anees Alhumaydhi, Fahad A. Tufail, Tabussam Shariati, Mohammad Ali Rebezov, Maksim Almarhoon, Zainab M. Mabkhot, Yahia N. Alsayari, Abdulrhman Rengasamy, Kannan R. R. Int J Environ Res Public Health Review Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronavirus. Interestingly, the virus binds with angiotensin-converting enzyme-2 found in host cells, through the spike (S) protein that exists on its surface. This binding causes the entry of the virus into cells of the host organism. The actual mechanism used by the COVID-19 virus to induce disease is still speculative. A total of 44,322,504 cases, a 1,173,189 death toll and 32,486,703 recovery cases have been reported in 217 countries globally as of 28 October 2020. Symptoms from the infection of the virus include chest pain, fever, fatigue, nausea, and others. Acute respiratory stress syndrome, arrhythmia, and shock are some of the chronic manifestations recorded in severe COVID-19. Transmission is majorly by individual-to-individual through coughing, sneezing, etc. The lack of knowledge regarding the mechanism of and immune response to the virus has posed a challenge in the development of a novel drug and vaccine. Currently, treatment of the disease involves the use of anti-viral medications such as lopinavir, remdesivir, and other drugs. These drugs show some efficacy in the management of COVID-19. Studies are still on-going for the development of an ideal and novel drug for treatment. In terms of natural product intervention, Traditional Chinese Medicines (TCM) have been employed to alleviate the clinical manifestation and severity of the disease and have shown some efficacy. This review presents an updated detailed overview of COVID-19 and the virus, concerning its structure, epidemiology, symptoms and transmission, immune responses, and current interventions, and highlights the potential of TCM. It is anticipated that this review will further add to the understanding of COVID-19 and the virus, hence opening new research perspectives. MDPI 2020-11-04 2020-11 /pmc/articles/PMC7662254/ /pubmed/33158234 http://dx.doi.org/10.3390/ijerph17218155 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rauf, Abdur
Abu-Izneid, Tareq
Olatunde, Ahmed
Ahmed Khalil, Anees
Alhumaydhi, Fahad A.
Tufail, Tabussam
Shariati, Mohammad Ali
Rebezov, Maksim
Almarhoon, Zainab M.
Mabkhot, Yahia N.
Alsayari, Abdulrhman
Rengasamy, Kannan R. R.
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
title COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
title_full COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
title_fullStr COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
title_full_unstemmed COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
title_short COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
title_sort covid-19 pandemic: epidemiology, etiology, conventional and non-conventional therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662254/
https://www.ncbi.nlm.nih.gov/pubmed/33158234
http://dx.doi.org/10.3390/ijerph17218155
work_keys_str_mv AT raufabdur covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT abuizneidtareq covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT olatundeahmed covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT ahmedkhalilanees covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT alhumaydhifahada covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT tufailtabussam covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT shariatimohammadali covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT rebezovmaksim covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT almarhoonzainabm covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT mabkhotyahian covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT alsayariabdulrhman covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies
AT rengasamykannanrr covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies